News
An MD/PhD Collaboration to Apply Hyperpolarized 13 C Metabolic MRI for Assessing Renal Tumor Aggressiveness in Patients
Jane Wang, MD and Peder Larson, PhD, faculty members in the UC San Francisco Department of Radiology and Biomedical Imaging are collaborating on a project applying hyperpolarized (HP) carbon 13 (13C) metabolic MRI in patients with renal tumors. The overall goal of their study is to improve risk
Targeted Therapy for ‘Undruggable’ Lung Cancer Stems from Decades of UCSF Research
Over the past two decades, targeted cancer therapies have changed the prognosis for thousands of patients. By targeting the specific genetic mutation behind a patient’s cancer, these therapies have enabled increasing numbers of patients to experience fewer toxic side effects and, often, live free of
Next-Generation T-Cell Therapeutics Set Sights on Cancers, Autoimmune Disorders and More
T cells – immune cells that patrol our bodies in search of trouble – have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells themselves as a form of medicine. “From my perspective there’s no more important system in the body than the
Examining Leukemia Risks Among Children with Down Syndrome
Down syndrome is one of the most common genetic conditions in the U.S. and Canada. According to the Centers for Disease Control and Prevention (CDC), about 6,000 babies with Down syndrome are born in the U.S. each year. When compared with the general population, children born with Down syndrome have
UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best in 2021-2022 US News & World Report
UCSF Benioff Children’s Hospitals have been recognized among the nation’s best pediatric medical centers in all 10 specialties assessed in U.S. News & World Report’s annual survey of Best Children’s Hospitals for 2021-2022, reflecting the quality of specialty care the hospitals provide for children
Living Therapeutics Initiative Will Accelerate Development and Delivery of Revolutionary Treatments
UC San Francisco is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients. The Living
Space Travel Weakens Our Immune Systems – Now Scientists May Know Why
Microgravity in space perturbs human physiology and is detrimental for astronaut health, a fact first realized during early Apollo missions when astronauts experienced inner ear disturbances, heart arrhythmia, low blood pressure, dehydration, and loss of calcium from their bones after their missions